Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that leads to cognitive decline, memory loss, and eventually, complete loss of independent functioning. The molecular mechanisms underlying Alzheimer's disease remain complex and are the subject of extensive research. This article provides an overview of the key molecular pathways involved in AD, focusing on amyloid-beta accumulation, tau hyperphosphorylation, and neuroinflammation. We also discuss recent advances in understanding the genetic and environmental factors contributing to AD, along with potential therapeutic strategies aimed at halting or reversing disease progression.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2020 Dr. David Parker (Author)